In this podcast, Robert Klein, DPM, CWS, speaks about split-thickness skin grafting, including the optimal thickness and the advantages and disadvantages of split-thickness skin grafting.

In this podcast, Soontharee Congrete, MD, talks about her team's latest study that investigated whether lactic acid could help determine which patients with pulmonary embolism have a high risk for decompensation.

In this podcast, Regina Gouder, FNP-C, APN, speaks about how uterine fibroids are detected, the gold standard treatment options, and what primary care physicians need to know about screening for uterine fibroids.

In this podcast, Dhiman Basu, MD, highlights current treatment options for patients with rheumatoid arthritis (RA), findings from a phase 4 clinical trial that assessed the safety and efficacy of repository corticotropin injection among patients with refractory disease, and more.

Linda Grinnell-Merrick, MS, NP-BC, immediate past president of the Rheumatology Nurses Society, discusses the importance of a comprehensive evaluation of a patient with PsA, nonpharmacologic and pharmacologic therapies available to manage the condition, and more.

In this 13-minute podcast, Jonathan Stine, MD, from the Milton S. Hershey Medical Center at Pennsylvania State University, discusses his proof-of-concept study concerning the relationship of nonalcoholic fatty liver disease and gut dysbiosis and how exercise can improve outcomes.

In this podcast, Iris Navarro-Millán, MD, MSPH, from Hospital for Special Surgery, discusses shared decision-making in rheumatoid arthritis, why a rheumatologist should understand patient perspectives in care, which patient-reported outcomes are most important for rheumatologists to consider during treatment, and more.

In this podcast, Christian Sandrock, MD, MPH, talks about how the current burden of community-acquired bacterial pneumonia (CABP) has impacted clinicians' concerns about the future, the increasing burden of treatment-resistant bacteria, and the resulting treatment limitations. This is part 3 of 3 podcasts on CABP from Dr Sandrock.

In this podcast, Christian Sandrock, MD, MPH, talks about how the causative agents of community-acquired bacterial pneumonia (CABP) are identified and how patient characteristics and type of bacteria affect treatment options, duration, and the patient journey. This is part 2 of 3 podcasts on CABP from Dr Sandrock.

In this podcast, Christian Sandrock, MD, MPH, talks about the burden of community-acquired bacterial pneumonia (CABP) in the United States, including the financial burden, the burden on hospitals, and readmission rates. This is part 1 of 3 podcasts on CABP from Dr Sandrock.